Objective: To explore the effectiveness and safety of pregnant women and newborns exposed to highly active antiretroviral therapy( HAART) during pregnancy. To observe the pregnant results and changes of maternal or fetal hematopoiesis and immune function in two different regimens of HAART.Methods: According to the different HAART regimens,71 HIV-infected pregnant women with single birth were divided into 2 groups,40 of containingzidovudine( AZT) group( AZT group),31 of AZT-free group,40 healthy pregnant wom...
【基金】
广西卫计委重点课题(桂卫重2010007)
【更新日期】
2018-05-22
【分类号】
R714.251
【正文快照】
zidovudine(AZT)group(AZT group),31 of AZT-free group,40 healthy pregnant women werein the control group.The antiretroviral therapy begun in or after the 14th pregnant week.TheHAART regimens of the AZT group were AZT+3TC+LPV/r or+EFV or+NVP,and the regi-me